These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 12938660)

  • 1. [The usage of different antidepressants in therapy of obsessive-compulsive disorders].
    Granenov GM; Mosolov SN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2003; 103(7):70-4. PubMed ID: 12938660
    [No Abstract]   [Full Text] [Related]  

  • 2. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison.
    Freeman CP; Trimble MR; Deakin JF; Stokes TM; Ashford JJ
    J Clin Psychiatry; 1994 Jul; 55(7):301-5. PubMed ID: 8071291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. When fluvoxamine treats only depression and clomipramine treats only obsessive-compulsive disorder--combine them?
    Schaller JL; Behar D; Chamberlain T
    J Neuropsychiatry Clin Neurosci; 1998; 10(1):111-3. PubMed ID: 9547477
    [No Abstract]   [Full Text] [Related]  

  • 4. Multicentre, double-blind, comparison of fluvoxamine and clomipramine in the treatment of obsessive-compulsive disorder.
    Mundo E; Maina G; Uslenghi C
    Int Clin Psychopharmacol; 2000 Mar; 15(2):69-76. PubMed ID: 10759337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacotherapy of obsessive compulsive disorder.
    Goodman WK; McDougle CJ; Price LH
    J Clin Psychiatry; 1992 Apr; 53 Suppl():29-37. PubMed ID: 1532962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What is the optimal approach to the pharmacological management of obsessive-compulsive disorder?
    Ravindran AV
    J Psychiatry Neurosci; 1998 Mar; 23(2):136. PubMed ID: 9549253
    [No Abstract]   [Full Text] [Related]  

  • 7. Fluvoxamine in obsessive-compulsive nonresponders to clomipramine or fluoxetine.
    Mattes JA
    Am J Psychiatry; 1994 Oct; 151(10):1524. PubMed ID: 8092352
    [No Abstract]   [Full Text] [Related]  

  • 8. Predictive value of obsessive-compulsive personality disorder in antiobsessional pharmacological treatment.
    Cavedini P; Erzegovesi S; Ronchi P; Bellodi L
    Eur Neuropsychopharmacol; 1997 Feb; 7(1):45-9. PubMed ID: 9088884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidepressant-induced hypomania in obsessive-compulsive disorder.
    Rihmer Z; Barsi J; Belsõ N; Pestality P; György S
    Int Clin Psychopharmacol; 1996 Sep; 11(3):203-5. PubMed ID: 8923100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antidepressants in the treatment of agoraphobia and obsessive-compulsive disorder.
    Mavissakalian M
    Compr Psychiatry; 1983; 24(3):278-84. PubMed ID: 6347516
    [No Abstract]   [Full Text] [Related]  

  • 11. Psychopharmacologic treatment of obsessive-compulsive disorder.
    Thorneloe WF
    J Med Assoc Ga; 1988 Nov; 77(11):825-6. PubMed ID: 3057098
    [No Abstract]   [Full Text] [Related]  

  • 12. Serotonin selectivity for obsessive compulsive and panic disorders.
    Montgomery SA; Bullock T; Fineberg N
    J Psychiatry Neurosci; 1991 Jul; 16(2 Suppl 1):30-5. PubMed ID: 1931935
    [No Abstract]   [Full Text] [Related]  

  • 13. [Critical analysis of controlled pharmacologic studies in obsessive compulsive disorder].
    Brochier T; Hantouche E
    Encephale; 1989; 15(3):325-33. PubMed ID: 8641159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonergic antidepressants and obsessive-compulsive disorder.
    Cialdella P; Boissel JP
    Am J Psychiatry; 1991 Oct; 148(10):1415-6. PubMed ID: 1832819
    [No Abstract]   [Full Text] [Related]  

  • 15. A controlled trial of fluvoxamine in obsessive-compulsive disorder: implications for a serotonergic theory.
    Jenike MA; Hyman S; Baer L; Holland A; Minichiello WE; Buttolph L; Summergrad P; Seymour R; Ricciardi J
    Am J Psychiatry; 1990 Sep; 147(9):1209-15. PubMed ID: 2143637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of drug therapy in the treatment of obsessive-compulsive disorders].
    Teeuwisse JM; Nolen WA
    Ned Tijdschr Geneeskd; 1989 Dec; 133(52):2605-8. PubMed ID: 2575230
    [No Abstract]   [Full Text] [Related]  

  • 17. Are effective antiobsessional drugs interchangeable?
    Tamimi RR; Mavissakalian MR
    Arch Gen Psychiatry; 1991 Sep; 48(9):857-9. PubMed ID: 1929778
    [No Abstract]   [Full Text] [Related]  

  • 18. Antiobsessional and antidepressant effects of clomipramine in the treatment of obsessive-compulsive disorder.
    Insel TR; Alterman I; Murphy DL
    Psychopharmacol Bull; 1982 Oct; 18(4):115-7. PubMed ID: 7156271
    [No Abstract]   [Full Text] [Related]  

  • 19. Compulsive personality as predictor of response to serotoninergic antidepressants.
    Ansseau M; Troisfontaines B; Papart P; von Frenckell R
    BMJ; 1991 Sep; 303(6805):760-1. PubMed ID: 1932937
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacologic treatment of anxiety disorders.
    Mavissakalian M
    J Clin Psychiatry; 1982 Dec; 43(12):487-91. PubMed ID: 6131065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.